Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang Peng

Showing results (361-370 of 381) with videos related to

Pageof 39
Sort By:
Cancer Cell|March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyChaoyang Sun, Jun Yin, Yong Fang, et al.
Zoological Research|May 28, 2021
Single-cell RNA sequencing reveals atlas of dairy goat testis cellsXiu-Wei Yu, Tong-Tong Li, Xiao-Min Du, et al.
World Journal of Gastroenterology|March 17, 2023
Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubinXiang-Jun Qian, Zhu-Mei Wen, Xiao-Ming Huang, et al.
Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Cancers|November 13, 2021
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and ManagementRichard K Yang, Gokce A Toruner, Wei Wang, et al.
Zoological Research|April 18, 2023
Transcription factor <i>Dmrt1</i> triggers the SPRY1-NF-κB pathway to maintain testicular immune homeostasis and male fertilityMeng-Fei Zhang, Shi-Cheng Wan, Wen-Bo Chen, et al.
Science Translational Medicine|June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancersChaoyang Sun, Yong Fang, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate CancerChao Wang, Guang Peng, Hai Huang, et al.
Cancer Cell|February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerDaniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Cell Reports. Medicine|December 20, 2023
PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibitionYang Li, Lacey E Dobrolecki, Christina Sallas, et al.
Pageof 39

Showing results (361-370 of 381) with videos related to

Sort By:
Pageof 39
Cancer Cell|March 14, 2018
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyChaoyang Sun, Jun Yin, Yong Fang, et al.
Zoological Research|May 28, 2021
Single-cell RNA sequencing reveals atlas of dairy goat testis cellsXiu-Wei Yu, Tong-Tong Li, Xiao-Min Du, et al.
World Journal of Gastroenterology|March 17, 2023
Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubinXiang-Jun Qian, Zhu-Mei Wen, Xiao-Ming Huang, et al.
Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.
Cancers|November 13, 2021
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and ManagementRichard K Yang, Gokce A Toruner, Wei Wang, et al.
Zoological Research|April 18, 2023
Transcription factor <i>Dmrt1</i> triggers the SPRY1-NF-κB pathway to maintain testicular immune homeostasis and male fertilityMeng-Fei Zhang, Shi-Cheng Wan, Wen-Bo Chen, et al.
Science Translational Medicine|June 2, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancersChaoyang Sun, Yong Fang, Jun Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate CancerChao Wang, Guang Peng, Hai Huang, et al.
Cancer Cell|February 29, 2020
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient CancerDaniel J McGrail, Jeannine Garnett, Jun Yin, et al.
Cell Reports. Medicine|December 20, 2023
PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibitionYang Li, Lacey E Dobrolecki, Christina Sallas, et al.
Pageof 39